FDA NDC Directory · JSON-LD · Markdown

OLANZAPINE

NDC 13668-090 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerTorrent Pharmaceuticals Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA091415
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsOLANZAPINE (20 mg/1)
Marketing started20111025
Package count3

External sources

Source: openFDA. Public-domain (CC0).